AUSTRALIAN medical cannabis sales tanked by over a quarter in the second half of 2025, following a clampdown on the
Repeal campaigns stall in Arizona as Idaho medical cannabis activists oversubscribe their ballot push, fresh research on legalisation arrests lands, and the industry’s medical-marketing claims and Tilray’s expansion playbook draw scrutiny.
Today’s cannabis news is dominated by rescheduling momentum, with operators racing to secure DEA Schedule III status even as the White House raises fresh concerns over high-potency products, while the UK, Brazil and Idaho underline how rapidly access is broadening on multiple fronts.
Trump targets hemp products, DEA pushes medical cannabis operators toward Schedule III registration, a major lawsuit hits industry therapeutic claims, Curaleaf marks a UK manufacturing first, and Virginia’s adult-use sales bill awaits the governor’s signature.
Cannabis drugmakers prepare for IPOs, nearly 400 operators rush to register with the DEA, microdosing data reframes consumer use patterns, and regulators from Israel to the Bahamas reshape their frameworks as Schedule III aftershocks ripple worldwide.
Reclassification confusion, an IPO revival in cannabis pharma and a contentious DEA registration form dominate today’s cannabis news, alongside fresh European consolidation and a return of investor focus on the sector’s ETFs.
Reform momentum builds on both sides of the Atlantic as Richard Branson presses for UK cannabis change, Indiana’s governor signals openness to legalisation, and analysts map the banking access unlocked by US rescheduling.
Today’s cannabis briefing covers the fallout from the US Justice Department’s Schedule III order, fresh travel guidance for UK medical patients, California’s ten-year legalisation milestone, environmental scrutiny at a Trulieve mega-grow, and a notable state-level legalisation recommendation in North Carolina.
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the
VIRGINIA CANNABIS Virginia House panel kills GOP-led push to legalize retail cannabis sales Benzinga reports that Virginia lawmakers struck down
NEW YORK LAWSUIT Judge rejects New York challenge to suit that’s delaying cannabis store openings MJ Biz Daily reports that
INSPIRE TECHNOLOGY Three firms steer e-cig and cannabis firm’s $42m IPO filing Law 360 reports that the e-cigarette and cannabis
NEW LAWS New year brings new laws, rules for cannabis businesses in the US MJ Biz Daily explores how businesses
QUESTIONS FOR CONGRESS FDA’s inaction on CBD regulations means more cannabis questions for Congress The FDA’s announcement that it won’t
SHARE-PRICE WARNING The Nasdaq stock exchange warns Organigram Holdings about their share price The Nasdaq stock exchange has warned Organigram
SOCIAL EQUITY PROGRAM The Parent Company announces details of the company’s Social Equity Ventures Brand Success Program Benzinga reports that
TO THE SENATE Minnesota House committee approves cannabis legalization bill Marijuana Moment reports that a third Minnesota House committee has
CANNABIS RESEARCH FDA issues clinical research guidance for cannabis Benzinga reports that The FDA has now issued final guidance outlining
We won’t spam you
